InHandPlus
PrivateLast Round
Series A
Jul 7, 2023
Total Funding Raised
$3.68M
Company Overview
InHandPlus operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in July 2023.
InHandPlus is a healthcare technology company that provides an AI-based smartwatch and application for medication management.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Devices, Patient Engagement, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InHandPlus Comparables
Compare InHandPlus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RxCap | 79% | |
| Vivalink | 75% | |
| etectRx | 72% |
For institutional investors. Book with your work email.
InHandPlus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 7, 2023 | ||||
| Pre Seed | Nov 25, 2020 | ||||
| Grant | Jul 1, 2019 | ||||
| Seed | Jun 27, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InHandPlus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genaxis | Series A |
| Strong Ventures | Pre Seed, Series A |
| IPS Ventures | Pre Seed, Series A |
| Maple Investment Partners | Series A |
| POSTECH Holdings | Pre Seed, Seed, Grant |
| Muirwoods Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Added Biozka, a startup in the pharmaceutical industry, as a customer.
- Nov 25, 2020
Raised $1.35M from POSTECH Holdings and Strong Ventures.
For institutional investors. Book with your work email.
InHandPlus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InHandPlus's valuation, stock price, and market status.
Is InHandPlus a public or private company?
InHandPlus is a private company.
What is the current stock price of InHandPlus?
InHandPlus is a private company, so its shares have no public market price. Caplight tracks InHandPlus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InHandPlus worth (valuation)?
Valuation information for InHandPlus is not publicly available.
Can I buy InHandPlus stock?
InHandPlus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InHandPlus's last funding round?
InHandPlus's most recent funding round was Series A on July 7, 2023.
Who are the main investors in InHandPlus?
Key investors in InHandPlus include Genaxis, Strong Ventures, IPS Ventures, Maple Investment Partners, POSTECH Holdings.
Will InHandPlus IPO soon?
No public IPO plans have been announced for InHandPlus.
How can I track InHandPlus secondary market activity?
Caplight tracks bids, offers, and trades in InHandPlus's shares on secondary markets.